Mobia Medical, Inc. (MOBI) investor relations documents from the company's IR site: 1 presentation, 7 press releases; latest deck 2026-08-13. Read in-app with summaries. First-party data.
Mobia Medical Investor Presentation — Mobia Medical provides the Vivistim System, an FDA-approved VNS therapy for chronic stroke recovery, reporting 102% year-over-year revenue growth in 2Q26.
| Published | Type | Document |
|---|---|---|
| 2026-08-13 | Presentation | Mobia Medical Investor Presentation |
| 2026-08-11 | Press release | Mobia Medical Reports Second Quarter 2026 Financial Results |
| 2026-07-21 | Press release | Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026 |
| 2026-07-15 | Press release | Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors |
| 2026-07-14 | Press release | Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Rec |
| 2026-07-02 | Press release | Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital |
| 2026-05-07 | Press release | Mobia Medical Announces Pricing of Initial Public Offering |
| Press release | Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy |
MOBI overview · MOBI earnings · MOBI financials · MOBI KPIs · MOBI ownership · MOBI peers · MOBI filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.